Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Frederic Colombel

Showing results (261-270 of 462) with videos related to

Pageof 47
Sort By:
The American Journal of Gastroenterology|October 24, 2003
Management of Crohn's disease of the ileoanal pouch with infliximabJean-Frederic Colombel, Elena Ricart, Edward V Loftus, et al.
Gastroenterology|February 6, 2004
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's diseasePaul Rutgeerts, Brian G Feagan, Gary R Lichtenstein, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 8, 2008
Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free dietJacques Cosnes, Christophe Cellier, Sheila Viola, et al.
Carcinogenesis|July 12, 2013
The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγChristel Rousseaux, Noura El-Jamal, Mathurin Fumery, et al.
Journal of Crohn'S & Colitis|December 9, 2023
Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn's Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 StudiesJean-Frederic Colombel, Stefan Schreiber, Geert D'Haens, et al.
Inflammatory Bowel Diseases|October 12, 2017
Epicutaneous Tolerance Induction to a Bystander Antigen Abrogates Colitis and Ileitis in MiceDavid Dunkin, M Cecilia Berin, Lucie Mondoulet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 17, 2021
Constrictive and Hypertrophic Strictures in Ileal Crohn's DiseaseQingqing Liu, Xiaofei Zhang, Huaibin Mabel Ko, et al.
Journal of the American Academy of Dermatology|December 29, 2016
Inflammatory bowel disease among patients with psoriasis treated with ixekizumab: A presentation of adjudicated data from an integrated database of 7 randomized controlled and uncontrolled trialsKristian Reich, Craig Leonardi, Richard G Langley, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2015
Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, MinnesotaSiddhant Yadav, Siddharth Singh, Jithinraj Edakkanambeth Varayil, et al.
The American Journal of Gastroenterology|August 17, 2011
The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safetyGert Van Assche, James D Lewis, Gary R Lichtenstein, et al.
Pageof 47

Showing results (261-270 of 462) with videos related to

Sort By:
Pageof 47
The American Journal of Gastroenterology|October 24, 2003
Management of Crohn's disease of the ileoanal pouch with infliximabJean-Frederic Colombel, Elena Ricart, Edward V Loftus, et al.
Gastroenterology|February 6, 2004
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's diseasePaul Rutgeerts, Brian G Feagan, Gary R Lichtenstein, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 8, 2008
Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free dietJacques Cosnes, Christophe Cellier, Sheila Viola, et al.
Carcinogenesis|July 12, 2013
The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγChristel Rousseaux, Noura El-Jamal, Mathurin Fumery, et al.
Journal of Crohn'S & Colitis|December 9, 2023
Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn's Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 StudiesJean-Frederic Colombel, Stefan Schreiber, Geert D'Haens, et al.
Inflammatory Bowel Diseases|October 12, 2017
Epicutaneous Tolerance Induction to a Bystander Antigen Abrogates Colitis and Ileitis in MiceDavid Dunkin, M Cecilia Berin, Lucie Mondoulet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 17, 2021
Constrictive and Hypertrophic Strictures in Ileal Crohn's DiseaseQingqing Liu, Xiaofei Zhang, Huaibin Mabel Ko, et al.
Journal of the American Academy of Dermatology|December 29, 2016
Inflammatory bowel disease among patients with psoriasis treated with ixekizumab: A presentation of adjudicated data from an integrated database of 7 randomized controlled and uncontrolled trialsKristian Reich, Craig Leonardi, Richard G Langley, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2015
Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, MinnesotaSiddhant Yadav, Siddharth Singh, Jithinraj Edakkanambeth Varayil, et al.
The American Journal of Gastroenterology|August 17, 2011
The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safetyGert Van Assche, James D Lewis, Gary R Lichtenstein, et al.
Pageof 47